Tap News

All-cause mortality during COVID-19: No plague and a likely signature of mass homicide by government response

Technical Report (PDF Available) · June 2020 with 61,435 Reads

DOI: 10.13140/RG.2.2.24350.77125

Cite this publication

  • D. G. Rancourt at Ontario Civil Liberties Association
    • 37
    • Ontario Civil Liberties Association
    All-cause mortality during COVID-19: No plague and a
    likely signature of mass homicide by government
    Denis G. Rancourt, PhD
    Researcher, Ontario Civil Liberties Association (ocla.ca)
    Working report (not submitted for journal publication), published at Research Gate
    2 June 2020
    Summary / Abstract
    The latest data of all-cause mortality by week does not show a winter-burden mortality that is
    statistically larger than for past winters. There was no plague. However, a sharp “COVID peak”
    is present in the data, for several jurisdictions in Europe and the USA.
    This all-cause-mortality “COVID peak” has unique characteristics:
    • Its sharpness, with a full-width at half-maximum of only approximately 4 weeks;
    • Its lateness in the infectious-season cycle, surging after week-11 of 2020, which is
    unprecedented for any large sharp-peak feature;
    • The synchronicity of the onset of its surge, across continents, and immediately following
    the WHO declaration of the pandemic; and
    • Its USA state-to-state absence or presence for the same viral ecology on the same
    territory, being correlated with nursing home events and government actions rather
    than any known viral strain discernment.
    These “COVID peak” characteristics, and a review of the epidemiological history, and of
    relevant knowledge about viral respiratory diseases, lead me to postulate that the “COVID
    peak” results from an accelerated mass homicide of immune-vulnerable individuals, and
    individuals made more immune-vulnerable, by government and institutional actions, rather
    than being an epidemiological signature of a novel virus, irrespective of the degree to which the
    virus is novel from the perspective of viral speciation.
    Read the paper here: